[%brief%]
Non-replicating viral delivery of shVASH1 to treat heart failure.
Small molecule therapeutics that aid in clearing abnormal protein deposits observed in neurodegenerative diseases.
A novel mRNA-based therapy that induces corneal endothelium regeneration to restore vision loss
Synthetic antimicrobial peptides derived from wasp venom to treat antibiotic-resistant infections.
A method that maintains the viability and function of NK cells following cryopreservation, enabling the production, storage, and transportation of therapeutic doses of NK cells to treatment centers.
A combinatorial library of RGD peptide (arginine-glycine-aspartic acid)-based lipids designed to formulate lipid nanoparticles for targeted mRNA delivery to the liver and the spleen.
Hydroxycholesterols are used to formulate lipid nanoparticles (LNPs) for enhanced mRNA delivery into T cells.
A method to expand LNP delivery capabilities to include small scaffold proteins such as nanobodies, DARPins, and Mini proteins.